Efficacy and safety outcomes by baseline comorbidity and age in patients newly diagnosed with chronic myeloid leukemia in chronic phase (CML-CP) and treated with dasatinib or imatinib in DASISION Meeting Abstract
| Authors: | Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E.; Abaskharoun, M.; Sy, O.; Saglio, G. |
| Abstract Title: | Efficacy and safety outcomes by baseline comorbidity and age in patients newly diagnosed with chronic myeloid leukemia in chronic phase (CML-CP) and treated with dasatinib or imatinib in DASISION |
| Meeting Title: | 28th Sympsoium for the International Association for Comparative Research on Leukemia & Related Diseases (IACRLRD 2017) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 17 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2017 Oct 31-Nov 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-10-01 |
| Start Page: | S14 |
| End Page: | S15 |
| Language: | English |
| ACCESSION: | WOS:000425079400021 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2017.09.042 |
| Notes: | Meeting Abstract: CML-005 -- Source: Wos |
